Rady Children's Specialists of San Diego
University of London
University College - London
Hammersmith Hospital, London, University of Colorado School of Medicine
Dr. Richard Haas is director of the Neurometabolic Clinic at Rady Children's Hospital-San Diego and director of the Mitochondrial Disease Laboratory and a professor at UC San Diego School of Medicine.
After earning his medical degree from the University of London, he completed residencies in internal medicine, neurology and pediatrics, followed by a fellowship in pediatric neurology at the University of Colorado.
Dr. Haas's clinical interests include neurometabolic disease, general child neurology, Rett Syndrome, neuromuscular disease and neonatal neurology. In 1994, he established what is now the Mitochondrial and Metabolic Disease Center and laboratory at UC San Diego as a facility dedicated to the research and clinical evaluation of mitochondrial disorders. His attempt to merge research and patient care has been a hallmark of his career and has created a referral base of both domestic and international patients.
Dr. Haas's research focuses on mitochondrial disorders and the relationship between metabolic defects and serious neurological diseases. He and Robert Naviaux, M.D., Ph.D., identified mutations in mitochondrial polymerase activity as the cause of Alper's syndrome, a devastating childhood mitochondrial disease. He also recently collaborated with researchers at UC Irvine to study mitochondrial dysfunction in autism.
He serves on the editorial board of the European Journal of Pediatric Neurology and is a member of the scientific advisory board of the United Mitochondrial Disease Foundation. Dr. Haas reviews various journals, including Proceedings of the National Academy of Sciences, Journal of Pediatric Neurology, Annals of Neurology and Molecular Genetics and Metabolism.
As director and principal investigator for the North American Mitochondrial Disease Consortium training fellowship, he aims to train clinician scientists who will be able to bring promising new treatments for mitochondrial disease into the clinical arena.
Mitochondrial Disease: A Practical Approach for Primary Care Physicians
Haas RH, Parikh S, Falk MJ, Saneto RP, Wolf NI, Darrin N, Cohen BH
The In-Depth Evaluation of Suspected Mitochondrial Disease
Mitochondrial Medicine Society's Committee on Diagnosis, Haas RH, Parikh S, Falk MJ, Saneto RP, Wolf NI, Darrin N, Wong LJ, Cohen BH, Naviaux RK
A Modern Approach to the Treatment of Mitochondrial Disease
Parikh S, Saneto R, Falk MJ, Anselm I, Cohen BH, Haas R, Medicine Society TM
Mitochondrial disorders affecting the nervous system
Haas RH,Zolkipli Z
Endocrine Disorders in Primary Mitochondrial Disease
Al-Gadi IS, Haas RH, Falk MJ, Goldstein A, McCormack SE
Randomized dose-escalation trial of elamipretide in adults with primary mitochondrial myopathy
Karaa A, Haas R, Goldstein A, Vockley J, Weaver WD, Cohen BH
Mitochondrial Dysfunction in Aging and Diseases of Aging
Richard H. Haas
PubMed is a third-party website and not affiliated with Rady Children's Hospital-San Diego.
Rady Children's updates the Doctor Finder annually. We are not responsible for omissions or errors. Prior to making an appointment, please be sure to check with your health plan to confirm coverage. If you see an error or omission on a physician's profile page, please contact us at firstname.lastname@example.org.